Leissinger, C. Et Al. 2010. A prospective, randomized, and crossover study of an activated prothrombin complex concentrate for secondary prophylaxis in patients with hemophilia A and inhibitors (Pro-FEIBA): subject demographics and safety data. HAEMOPHILIA , vol.16 , 31.

Leissinger, C., Negrier, C., Berntorp, E., Windyga, J., Serban, M., Bulent, A., ... Lassila, R.(2010). A prospective, randomized, and crossover study of an activated prothrombin complex concentrate for secondary prophylaxis in patients with hemophilia A and inhibitors (Pro-FEIBA): subject demographics and safety data. HAEMOPHILIA , vol.16, 31.

Leissinger, C. Et Al. "A prospective, randomized, and crossover study of an activated prothrombin complex concentrate for secondary prophylaxis in patients with hemophilia A and inhibitors (Pro-FEIBA): subject demographics and safety data," HAEMOPHILIA , vol.16, 31, 2010

Leissinger, C. Et Al. "A prospective, randomized, and crossover study of an activated prothrombin complex concentrate for secondary prophylaxis in patients with hemophilia A and inhibitors (Pro-FEIBA): subject demographics and safety data." HAEMOPHILIA , vol.16, pp.31, 2010

Leissinger, C. Et Al. (2010) . "A prospective, randomized, and crossover study of an activated prothrombin complex concentrate for secondary prophylaxis in patients with hemophilia A and inhibitors (Pro-FEIBA): subject demographics and safety data." HAEMOPHILIA , vol.16, p.31.

@article{article, author={C. Leissinger Et Al. }, title={A prospective, randomized, and crossover study of an activated prothrombin complex concentrate for secondary prophylaxis in patients with hemophilia A and inhibitors (Pro-FEIBA): subject demographics and safety data}, journal={HAEMOPHILIA}, year=2010, pages={31} }